Patients should feel empowered to ask questions about their treatment plan, including why a particular GLP-1 medication was chosen, what specific monitoring is recommended, and when to seek urgent medical attention
Several studies have demonstrated that silencing fat mass and obesity-associated protein (FTO) and iron regulatory protein 2 (IRP2) mitigates abnormalities in the amino acid antioxidant system and ferroptosis, thereby attenuating dopaminergic neuronal damage
discussion 2523S-4S
Your provider will escalate your dose every four weeks based on your response and tolerance
That said, here are some groups of people who are typically not candidates for semaglutide or advised to use it with caution: History of Pancreatitis Individuals with a history of pancreatitis, which is inflammation of the pancreas, should avoid semaglutide due to the potential risk of exacerbating the condition
If your pharmacist has questions, they can refer to Savings Offer Processing Support for Pharmacists, below